COVINA, CA ---- 02/16/2006 -- Healtheuniverse Inc. (OTC:HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that research efforts are focused on being the first to commercialize non-embryonic stem cell use in the $15 billion worldwide plastic surgery and cosmetic surgery market. The Company intends to sell its proprietary technology through packaged products and licensing agreements, once human clinical trials are completed, to plastic and cosmetic surgeons as a simple way for the industry to utilize our proprietary technology worldwide.
Cosmetic surgery can be performed with stem-cell generated natural tissues instead of synthetic implants. Saline and silicone implants for breast augmentation may rupture, leak, and interfere with breast cancer detection on mammograms. Stem cell generated natural tissue implants created through the use of the Company's commercially packaged product line could provide a superior product and also avoid these problems.
"Engineered fat tissue from stem cells is the ideal solution for patients with wrinkles, contour irregularities, and for breast augmentation," stated Dr. Vipul Dev, MD Chief Executive Officer of Healtheuniverse, Inc. "By utilizing adult stem cells via Healtheuniverse's packaged product, we hope to effectively engineer fat tissue and provide worldwide access to the technology for a variety of commercial surgical and cosmetic applications."
Reconstructive surgery to replace tissues lost to cancer or other disease could benefit from stem-cell generated natural implants that do not shrink or lose their shape. Studies have shown that conventional soft tissue implants can lose 40 percent to 60 percent of their volume over time. Examples are breast tissue reconstruction after breast cancer surgery and facial soft tissue reconstruction following cancer or trauma surgeries.
Natural implants often require separate surgical procedures from a healthy location of the patient's body to obtain tissue for constructing the implant. The stem-cell approach does not require extensive surgery because cells needed for the implant are obtained in a less invasive needle procedure.
The market for plastic, reconstructive, and cosmetic surgery procedures today exceeds $15 billion per year. It's estimated that cosmetic surgery procedures represent approximately $10 billion of industry revenues. Plastic Surgery encompasses both reconstructive and aesthetic surgery, commonly referred to as cosmetic surgery. While not essential to physical health, aesthetic surgery can improve the appearance of normal body features and enhance self image.
About HEALTHeUNIVERSE Inc.
HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com
Safe Harbor Statement
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact: